First Quadrant’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-51,729
Closed -$1.04M 584
2020
Q4
$1.04M Buy
51,729
+41,317
+397% +$865K 0.1% 160
2020
Q3
$255K Sell
10,412
-6,498
-38% -$152K 0.03% 313
2020
Q2
$401K Buy
+16,910
New +$392K 0.05% 309
2019
Q4
Sell
-22,177
Closed -$392K 588
2019
Q3
$392K Buy
22,177
+17,510
+375% +$354K 0.04% 344
2019
Q2
$100K Sell
4,667
-1,658
-26% -$34.7K 0.01% 587
2019
Q1
$151K Buy
+6,325
New +$144K 0.01% 535
2018
Q3
Sell
-160,397
Closed -$3.45M 855
2018
Q2
$3.45M Hold
160,397
0.06% 265
2018
Q1
$3.55M Sell
160,397
-256,559
-62% -$7.09M 0.07% 259
2017
Q4
$12.7M Buy
416,956
+14,428
+4% +$384K 0.24% 141
2017
Q3
$9.75M Buy
402,528
+396,670
+6,771% +$10.6M 0.19% 172
2017
Q2
$144K Buy
+5,858
New +$124K ﹤0.01% 733

Other funds holding EXEL

First Quadrant's EXEL Position: Q1 2021 in Review

First Quadrant sold out of Exelixis (EXEL) in Q1 2021, closing a stake of 51,729 shares — an estimated $1.04M sold.

First Quadrant first reported a position in EXEL in Q2 2017 and held it in 11 quarters. The position peaked at $12.7M in Q4 2017. 347 funds tracked by Wall St. Rank hold EXEL as of Q1 2021.

  • First Quadrant reported no remaining Exelixis position as of Q1 2021 after selling out during the quarter.
  • First Quadrant sold 51,729 Exelixis shares in Q1 2021, an estimated $1.04M.
  • First Quadrant first reported a position in Exelixis in Q2 2017 and held it in 11 quarters.
  • First Quadrant's Exelixis position peaked at $12.7M in Q4 2017.
  • 347 funds tracked by Wall St. Rank held Exelixis as of Q1 2021.

Based on First Quadrant's 13F filing for Q1 2021, filed 27 Apr 2021.